Security key
03969K108
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT)
CUSIP: 03969K108
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 123,454,843
- Total 13F shares
- 128,641,664
- Share change
- +1,730,391
- Total reported value
- $1,198,282,493
- Put/Call ratio
- 17%
- Price per share
- $9.30
- Number of holders
- 187
- Value change
- +$15,921,001
- Number of buys
- 102
- Number of sells
- 77
Report period
Q3 2024
Institutions
187
Top holders
10
ARQT full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969K108
Recent filing periods:
Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC |
13F
|
Company |
9.4%
|
11,571,694
|
$107,616,756 | — | 30 Jun 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
8.1%
|
10,004,492
|
$93,041,776 | — | 30 Jun 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
8%
|
9,816,672
|
$91,295,050 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
7.1%
|
8,785,284
|
$81,703,141 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7%
|
8,622,618
|
$80,190,347 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
5.6%
|
6,879,072
|
$63,975,370 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
6,144,290
|
$57,141,898 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.2%
|
5,134,843
|
$47,754,040 | — | 30 Jun 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.6%
|
4,438,179
|
$41,275,065 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
3.2%
|
3,972,694
|
$36,946,060 | — | 30 Jun 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
2.9%
|
3,616,532
|
$33,633,744 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.4%
|
2,932,647
|
$27,273,617 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2%
|
2,525,000
|
$23,482,500 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
2,421,270
|
$22,522,362 | — | 30 Jun 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.7%
|
2,133,702
|
$19,843,430 | — | 30 Jun 2024 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
1.7%
|
2,041,108
|
$18,982,304 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.5%
|
1,882,025
|
$17,502,833 | — | 30 Jun 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.4%
|
1,667,979
|
$15,513,000 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.3%
|
1,558,500
|
$14,494,050 | — | 30 Jun 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
1.1%
|
1,343,609
|
$12,495,564 | — | 30 Jun 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
1.1%
|
1,311,549
|
$12,197,406 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
1,307,481
|
$12,159,006 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1%
|
1,285,078
|
$11,951,225 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1%
|
1,231,700
|
$11,454,821 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.9%
|
1,113,582
|
$10,356,000 | — | 30 Jun 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.83%
|
1,030,703
|
$9,585,538 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.82%
|
1,007,384
|
$9,368,671 | — | 30 Jun 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.78%
|
965,392
|
$8,978,146 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.76%
|
937,594
|
$8,719,624 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.69%
|
851,324
|
$7,917,313 | — | 30 Jun 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.68%
|
837,847
|
$7,791,977 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.65%
|
807,334
|
$7,508,206 | — | 30 Jun 2024 | |
| Two Seas Capital LP |
13F
|
Company |
0.62%
|
762,190
|
$7,088,367 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.61%
|
751,850
|
$6,992,205 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.6%
|
735,042
|
$6,835,891 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.54%
|
667,259
|
$6,205,509 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.51%
|
634,441
|
$5,900,301 | — | 30 Jun 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.46%
|
572,615
|
$5,325,320 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.46%
|
567,123
|
$5,274,244 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
563,171
|
$5,237,490 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.42%
|
512,696
|
$4,768,073 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.4%
|
489,642
|
$4,553,672 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.4%
|
488,600
|
$4,543,980 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.35%
|
437,362
|
$4,067,467 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.32%
|
390,202
|
$3,628,879 | — | 30 Jun 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.29%
|
359,997
|
$3,347,000 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.28%
|
350,114
|
$3,256,060 | — | 30 Jun 2024 | |
| FISHMAN JAY A LTD/MI |
13F
|
Company |
0.28%
|
346,600
|
$3,223,380 | — | 30 Jun 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.26%
|
319,715
|
$2,973,350 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
309,571
|
$2,879,010 | — | 30 Jun 2024 |
Institutional Holders of Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) as of Q3 2024
As of 30 Sep 2024,
Arcutis Biotherapeutics, Inc. - COMMON STOCK (ARQT) was held by
187 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
128,641,664 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, Rubric Capital Management LP, SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Frazier Life Sciences Management, L.P., VANGUARD GROUP INC, Polar Capital Holdings Plc, STATE STREET CORP, FRANKLIN RESOURCES INC, and MORGAN STANLEY.
This page lists
187
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
184
Q3 2024 holders
187
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.